𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interaction of sulphinpyrazone with warfarin

✍ Scribed by J. O. Miners; T. Foenander; S. Wanwimolruk; A. S. Gallus; D. J. Birkett


Publisher
Springer
Year
1982
Tongue
English
Weight
470 KB
Volume
22
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Fluorescence enhancement of warfarin ind
✍ Jacob M. Vasquez; Andrew Vu; Jerome S. Schultz; Valentine I. Vullev πŸ“‚ Article πŸ“… 2009 πŸ› American Institute of Chemical Engineers 🌐 English βš– 995 KB

## Abstract Warfarin is the most common agent used for control and prevention of venous as well as arterial thromboembolism (blood clots). In aqueous media, warfarin forms inclusion complexes with a family of cyclic oligosaccharides, Ξ±, Ξ², γ‐cyclodextrins (CD). The formation of these complexes resu

Absence of interaction between tenoxicam
✍ H.-G. Eichler; M. Jung; P. A. Kyrle; M. Rotter; A. Korn πŸ“‚ Article πŸ“… 1992 πŸ› Springer 🌐 English βš– 291 KB

The influence of tenoxicam on plasma warfarin concentrations and on its anticoagulant effect has been studied in healthy volunteers. Tenoxicam did not alter the plasma warfarin concentration versus time profile. Treatment with it for 14 days had no effect on the average dose of warfarin required to